FLUI
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Fluicell operates in biotechnology. The company conducts research and development in the processing of cell composition in the development of new drugs. The company has developed a product portfolio consisting of patented research instruments, which are used to study, analyze and ultimately process cells. In addition, there is expertise in 2D/3D printing. Fluicell was founded in 2012 and is headquartered in Gothenburg.
Read moreInterim report Q3'26
Annual report '26
Revenue M
EBIT-% (adj.)
EPS (adj.)
Dividend %
Don't miss out - create an account and get all the possible benefits